Tue.Aug 02, 2022

IDRx, a new biotech startup, raises $122M to develop better cancer drug combinations

Bio Pharma Dive

Founded by serial entrepreneur Alexis Borisy, the company comes equipped with two experimental medicines it licensed from Merck KGaA and Blueprint Medicines

Are online health searches private?

World of DTC Marketing

A Gizmodo investigation into some of the nation’s biggest data brokers found more than two dozen promoting access to datasets containing digital information on millions of pregnant and potentially pregnant people across the country.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

How Belite Bio, a small, under-the-radar drugmaker, emerged as one of biotech’s best performing IPOs

Bio Pharma Dive

Belite's shares have risen nearly 500% from their IPO price at a time when many other newly public biotech companies are struggling to hold their value


Biden Administration Facing Renewed Pressure to Legalize Cannabis

FDA Law Blog

By Larry K. Houck — At least one public interest group and several members of Congress remain frustrated with the Biden Administration’s failure to take action to legalize cannabis.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Strand CEO on founder-led biotech, venture capital and the market’s retreat

Bio Pharma Dive

Jake Becraft, founder and current chief of mRNA startup Strand Therapeutics, argues biotech would be healthier if more scientists and researchers lead the companies they start

Blending human knowhow, artificial intelligence aids drug discovery

Outsourcing Pharma

A leader from pharmaceutical firm Astellas discusses how the company has put to use a discovery platform that combines human expertise, AI, and robotics. Preclinical Research

Drugs 105

More Trending

Regeneron puts kibosh on 4 antibody studies as Pfizer's Paxlovid dominates the COVID treatment scene

Fierce Pharma

Regeneron puts kibosh on 4 antibody studies as Pfizer's Paxlovid dominates the COVID treatment scene. fkansteiner. Tue, 08/02/2022 - 10:29

With new data, Roche takes step toward more convenient cancer immunotherapy

Bio Pharma Dive

The pharma claimed Phase 3 study success for a subcutaneous version of its drug Tecentriq, a strategy it and rivals Merck and Bristol Myers could use to extend the market life of their lucrative drugs

Drugs 210

Roche scores phase 3 win for subcutaneous Tecentriq, eyes filings


Roche’s Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in a phase 3 trial.

EC’s HERA signs Covid-19 vaccine procurement deal with HIPRA

Pharmaceutical Technology

The Health Emergency Preparedness and Response Authority (HERA) of the European Commission (EC) has entered a co-procurement framework contract for HIPRA HUMAN HEALTH’s bivalent recombinant protein Covid-19 vaccine.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

How the WHO hepatitis strategy measures up in the field


According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis B, with most unaware of their infection. Africa is the worst impacted region for hepatitis B with a prevalence of 7.5 percent compared to 0.5 percent in the Americas.

Implementation of electronic health records will improve the quality of care

Pharmaceutical Technology

The increasing digitisation of the healthcare sector is enabling real-time access to patient-related data in a manner that was not previously possible.

Dexcom ONE glucose monitoring system available on prescription


System improves management for people with diabetes by offering finger prick-free monitoring


AbbVie, bracing for biosim impact, scores another win against Humira antitrust allegations

Fierce Pharma

AbbVie, bracing for biosim impact, scores another win against Humira antitrust allegations. zbecker. Tue, 08/02/2022 - 11:11


Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Oncology market dominance: As easy as ADC?


Antibody-drug conjugates are coming back to the fore, with talks of multi-billion dollar buyouts and a rapidly growing number of approvals. Ben Hargreaves examines why the interest in the area is growing, at the same time as others express doubts about its potential.

Sales 82

Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data

Fierce Pharma

Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data. ntaylor. Tue, 08/02/2022 - 07:24


Post Marketing Research


Premarketing drug studies vs Post- Marketing research. Premarketing drug studies consist of phase I-III trials, and are represented by pharmacokinetic and pharmacodynamic studies, dose ranging studies, and Randomized Controlled Trials (RCTs).

Sosei Heptares and AbbVie to develop therapies for neurological ailments

Pharmaceutical Technology

Sosei Heptares , a corporate brand of Sosei Group Corporation, has signed a new drug discovery partnership and option-to-license agreement with AbbVie for discovering, developing and marketing new therapies for neurological ailments.

FDA Approves GSK’s Benlysta (belimumab) for Pediatric Patients with Lupus Nephritis


On July 27, 2022, GSK announced that the US Food and Drug Administration (FDA) has approved Benlysta (belimumab) as an intravenous treatment for lupus and active lupus nephritis (LN) in children between the ages of 5 and 17 who are receiving standard therapy.

Samsung Biologics, GreenLight conclude Covid-19 vaccine engineering run

Pharmaceutical Technology

Samsung Biologics and GreenLight Biosciences have completed the initial commercial-scale engineering run for their messenger ribonucleic acid (mRNA) Covid-19 vaccine under their manufacturing collaboration. Last year, the companies entered a strategic collaboration.

AbbVie taps Sosei Heptares GPCR expertise with $1.2bn+ alliance


Sosei Heptares has signed up a string of big pharma collaborators over the last few years, and one of them – AbbVie – has just expanded its partnership with a new to deal to apply the biotech’s G protein-coupled receptor (GPCR) expertise to the discovery of drugs for neurological diseases.

Synthego breaks ground on sgRNA manufacturing facility

BioPharma Reporter

The company plans to use the additional capacity to manufacture synthetic sgRNAs, used in the development of CRISPR-mediated cell and gene therapies. Upstream Processing

The Shady Business of Specialty Carve-Outs

Drug Channels

Watch out! Plan sponsors are getting even bolder in their attempts to grab financial support intended for patients. The latest scam is called a specialty carve-out. Here’s the game: A commercial plan eliminates coverage for all specialty drugs.

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement.

Shaping Strategies for a New Era of Engagement and Commercialization

Pharmaceutical Commerce

With the business model changing and the patent cliff looming, Ashfield Engage's Chris Savage talks about what these upheavals mean for pharma companies, their sales reps, and their patients.

Sales 52

The Benefits of Blister Packaging

Pharma Packaging Solutions

If you have ever taken any kind of medication, be it prescription or over the counter (and you almost certainly have), then you’re probably familiar with blister packaging. Blister packaging is extremely common in the pharmaceutical industry, thanks to its many benefits. Intuitive Dosage.

SCHOTT Creates Stand-alone Company for Pharma Business

Pharmaceutical Commerce

Division will operate under SCHOTT Pharma AG & Co.


US FDA grants approval for Janssen’s Stelara to treat psoriatic arthritis

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) ’s Stelara (ustekinumab) to treat paediatric patients aged six years and above with active psoriatic arthritis (PsA).

Rethinking Pharma Commercialization Models as Healthcare Evolves

Pharmaceutical Commerce

How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies.


Short, Practical, & Printable: Quick Guides & More

Triage Cancer

Navigating the legal and practical issues that most people encounter after a cancer diagnosis can feel overwhelming. Triage Cancer takes complex topics, like health insurance, and breaks them down into easy-to-understand terms, in the form of free Quick Guides, Checklists, & Worksheets.

New revelations from monkeypox outbreak study


Unique skin symptoms of the current monkeypox outbreak include pseudo-pustules


Shionogi starts pivotal Japanese trial of Akili’s ADHD app


A Japanese language version of Akili Interactive’s EndeavorRx ground-breaking digital therapy for attention deficit hyperactivity disorder (ADHD) has started a phase 3 trial, with results due next year.

Life Sciences in NYC: An Innovation Hub of Unmatched Diversity and Talent

Pharmaceutical Commerce


Packaging Materials, Containers and Containment Services

Pharmaceutical Technology

Packaging plays a critical role in the protection of drug and pharmaceutical products from damage and contamination. Pharmaceutical companies use a range of packaging materials to preserve the integrity of their products. The choice of materials used in pharmaceutical packaging depends on the type of drug or pharmaceutical product being packaged. Pharmaceutical companies need to consider factors such as the degree of required protection, the dosage, convenience of use and cost of packaging.